(SMG) Scotts Miracle-Gro - Ratings and Ratios
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US8101861065
Lawn Care, Fertilizer, Seeds, Hydroponics, Pest Control
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.47% |
| Yield on Cost 5y | 1.36% |
| Yield CAGR 5y | 0.77% |
| Payout Consistency | 90.2% |
| Payout Ratio | 71.0% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 42.0% |
| Value at Risk 5%th | 60.0% |
| Relative Tail Risk | -13.09% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.15 |
| Alpha | -23.32 |
| CAGR/Max DD | 0.11 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.330 |
| Beta | 0.952 |
| Beta Downside | 0.958 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.26% |
| Mean DD | 25.60% |
| Median DD | 26.52% |
Description: SMG Scotts Miracle-Gro January 10, 2026
The Scotts Miracle-Gro Company (NYSE:SMG) manufactures and markets a broad portfolio of lawn, garden and indoor-hydroponic products under brands such as Scotts, Miracle-Gro, Ortho and AeroGarden. Its offerings span traditional fertilizers, seed and pest-control items to high-tech hydroponic lighting and nutrient systems, sold through big-box retailers, e-commerce sites and specialty growers worldwide. The firm, founded in 1868 and based in Marysville, Ohio, operates primarily in the Fertilizers & Agricultural Chemicals sub-industry.
Key recent metrics: SMG generated roughly $5.0 billion in revenue for FY 2023, with a 7 % YoY increase driven by strong demand for premium lawn care and a 12 % rise in its hydroponics segment (≈$300 million). The business benefits from macro-drivers such as higher consumer spending on home improvement (U.S. home-center sales up ~5 % YoY) and a secular shift toward indoor gardening, which has grown at a CAGR of ~15 % since 2020. Conversely, exposure to volatile fertilizer input costs and regulatory scrutiny of weed-killer products (e.g., Roundup litigation) adds downside risk.
For a deeper dive into SMG’s valuation metrics and scenario analysis, the ValueRay platform offers a concise, data-driven overview.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 145.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA -10.33 > 1.0 |
| NWC/Revenue: 5.88% < 20% (prev 6.48%; Δ -0.60% < -1%) |
| CFO/TA 0.14 > 3% & CFO 371.3m > Net Income 145.3m |
| Net Debt (2.07b) to EBITDA (425.6m): 4.86 < 3 |
| Current Ratio: 1.27 > 1.5 & < 3 |
| Outstanding Shares: last quarter (57.7m) vs 12m ago 1.41% < -2% |
| Gross Margin: 30.59% > 18% (prev 0.24%; Δ 3035 % > 0.5%) |
| Asset Turnover: 121.6% > 50% (prev 123.7%; Δ -2.11% > 0%) |
| Interest Coverage Ratio: 2.72 > 6 (EBITDA TTM 425.6m / Interest Expense TTM 128.8m) |
Altman Z'' 1.85
| A: 0.07 (Total Current Assets 940.3m - Total Current Liabilities 739.7m) / Total Assets 2.74b |
| B: 0.11 (Retained Earnings 294.7m / Total Assets 2.74b) |
| C: 0.12 (EBIT TTM 350.6m / Avg Total Assets 2.81b) |
| D: 0.17 (Book Value of Equity 536.6m / Total Liabilities 3.10b) |
| Altman-Z'' Score: 1.85 = BBB |
Beneish M -3.13
| DSRI: 1.10 (Receivables 186.9m/176.8m, Revenue 3.41b/3.55b) |
| GMI: 0.78 (GM 30.59% / 23.94%) |
| AQI: 1.21 (AQ_t 0.43 / AQ_t-1 0.35) |
| SGI: 0.96 (Revenue 3.41b / 3.55b) |
| TATA: -0.08 (NI 145.3m - CFO 371.3m) / TA 2.74b) |
| Beneish M-Score: -3.13 = AA |
ValueRay F-Score (Strict, 0-100) 49.70
| 1. Piotroski: 3.0pt |
| 2. FCF Yield: 4.76% |
| 3. FCF Margin: 8.02% |
| 4. Debt/Equity: -5.89 |
| 5. Debt/Ebitda: 4.86 |
| 6. ROIC - WACC: 4.85% |
| 7. RoE: -44.78% |
| 8. Revenue Trend: -14.25% |
| 9. EPS Trend: -3.54% |
What is the price of SMG shares?
As of January 23, 2026, the stock is trading at USD 62.32 with a total of 610,935 shares traded.
Over the past week, the price has changed by -2.79%, over one month by +5.23%, over three months by +15.06% and over the past year by -8.79%.
Over the past week, the price has changed by -2.79%, over one month by +5.23%, over three months by +15.06% and over the past year by -8.79%.
Is SMG a buy, sell or hold?
Scotts Miracle-Gro has received a consensus analysts rating of 4.36.
Therefore, it is recommended to buy SMG.
- Strong Buy: 7
- Buy: 1
- Hold: 3
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the SMG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 72.8 | 16.9% |
| Analysts Target Price | 72.8 | 16.9% |
| ValueRay Target Price | 68.2 | 9.4% |
SMG Fundamental Data Overview January 18, 2026
P/E Trailing = 25.753
P/E Forward = 14.8148
P/S = 1.0811
P/B = 18.9789
P/EG = 0.2612
Revenue TTM = 3.41b USD
EBIT TTM = 350.6m USD
EBITDA TTM = 425.6m USD
Long Term Debt = 2.05b USD (from longTermDebt, last quarter)
Short Term Debt = 57.2m USD (from shortTermDebt, last quarter)
Debt = 2.11b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.07b USD (from netDebt column, last quarter)
Enterprise Value = 5.76b USD (3.69b + Debt 2.11b - CCE 36.6m)
Interest Coverage Ratio = 2.72 (Ebit TTM 350.6m / Interest Expense TTM 128.8m)
EV/FCF = 21.03x (Enterprise Value 5.76b / FCF TTM 273.9m)
FCF Yield = 4.76% (FCF TTM 273.9m / Enterprise Value 5.76b)
FCF Margin = 8.02% (FCF TTM 273.9m / Revenue TTM 3.41b)
Net Margin = 4.26% (Net Income TTM 145.3m / Revenue TTM 3.41b)
Gross Margin = 30.59% ((Revenue TTM 3.41b - Cost of Revenue TTM 2.37b) / Revenue TTM)
Gross Margin QoQ = 6.07% (prev 31.82%)
Tobins Q-Ratio = 2.10 (Enterprise Value 5.76b / Total Assets 2.74b)
Interest Expense / Debt = 1.27% (Interest Expense 26.8m / Debt 2.11b)
Taxrate = 34.51% (76.5m / 221.7m)
NOPAT = 229.6m (EBIT 350.6m * (1 - 34.51%))
Current Ratio = 1.27 (Total Current Assets 940.3m / Total Current Liabilities 739.7m)
Debt / Equity = -5.89 (negative equity) (Debt 2.11b / totalStockholderEquity, last quarter -357.5m)
Debt / EBITDA = 4.86 (Net Debt 2.07b / EBITDA 425.6m)
Debt / FCF = 7.56 (Net Debt 2.07b / FCF TTM 273.9m)
Total Stockholder Equity = -324.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.18% (Net Income 145.3m / Total Assets 2.74b)
RoE = -44.78% (negative equity) (Net Income TTM 145.3m / Total Stockholder Equity -324.5m)
RoCE = 20.33% (EBIT 350.6m / Capital Employed (Equity -324.5m + L.T.Debt 2.05b))
RoIC = 11.15% (NOPAT 229.6m / Invested Capital 2.06b)
WACC = 6.30% (E(3.69b)/V(5.80b) * Re(9.42%) + D(2.11b)/V(5.80b) * Rd(1.27%) * (1-Tc(0.35)))
Discount Rate = 9.42% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.88%
[DCF Debug] Terminal Value 78.65% ; FCFF base≈397.7m ; Y1≈261.1m ; Y5≈119.1m
Fair Price DCF = 22.55 (EV 3.38b - Net Debt 2.07b = Equity 1.31b / Shares 58.0m; r=6.30% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -3.54 | EPS CAGR: -17.43% | SUE: 0.08 | # QB: 0
Revenue Correlation: -14.25 | Revenue CAGR: -9.62% | SUE: 0.09 | # QB: 0
EPS next Quarter (2026-03-31): EPS=4.03 | Chg30d=+0.035 | Revisions Net=-2 | Analysts=7
EPS current Year (2026-09-30): EPS=4.34 | Chg30d=+0.028 | Revisions Net=+8 | Growth EPS=+16.1% | Growth Revenue=+0.7%
EPS next Year (2027-09-30): EPS=4.98 | Chg30d=-0.014 | Revisions Net=-1 | Growth EPS=+14.7% | Growth Revenue=+2.3%
P/E Forward = 14.8148
P/S = 1.0811
P/B = 18.9789
P/EG = 0.2612
Revenue TTM = 3.41b USD
EBIT TTM = 350.6m USD
EBITDA TTM = 425.6m USD
Long Term Debt = 2.05b USD (from longTermDebt, last quarter)
Short Term Debt = 57.2m USD (from shortTermDebt, last quarter)
Debt = 2.11b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.07b USD (from netDebt column, last quarter)
Enterprise Value = 5.76b USD (3.69b + Debt 2.11b - CCE 36.6m)
Interest Coverage Ratio = 2.72 (Ebit TTM 350.6m / Interest Expense TTM 128.8m)
EV/FCF = 21.03x (Enterprise Value 5.76b / FCF TTM 273.9m)
FCF Yield = 4.76% (FCF TTM 273.9m / Enterprise Value 5.76b)
FCF Margin = 8.02% (FCF TTM 273.9m / Revenue TTM 3.41b)
Net Margin = 4.26% (Net Income TTM 145.3m / Revenue TTM 3.41b)
Gross Margin = 30.59% ((Revenue TTM 3.41b - Cost of Revenue TTM 2.37b) / Revenue TTM)
Gross Margin QoQ = 6.07% (prev 31.82%)
Tobins Q-Ratio = 2.10 (Enterprise Value 5.76b / Total Assets 2.74b)
Interest Expense / Debt = 1.27% (Interest Expense 26.8m / Debt 2.11b)
Taxrate = 34.51% (76.5m / 221.7m)
NOPAT = 229.6m (EBIT 350.6m * (1 - 34.51%))
Current Ratio = 1.27 (Total Current Assets 940.3m / Total Current Liabilities 739.7m)
Debt / Equity = -5.89 (negative equity) (Debt 2.11b / totalStockholderEquity, last quarter -357.5m)
Debt / EBITDA = 4.86 (Net Debt 2.07b / EBITDA 425.6m)
Debt / FCF = 7.56 (Net Debt 2.07b / FCF TTM 273.9m)
Total Stockholder Equity = -324.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.18% (Net Income 145.3m / Total Assets 2.74b)
RoE = -44.78% (negative equity) (Net Income TTM 145.3m / Total Stockholder Equity -324.5m)
RoCE = 20.33% (EBIT 350.6m / Capital Employed (Equity -324.5m + L.T.Debt 2.05b))
RoIC = 11.15% (NOPAT 229.6m / Invested Capital 2.06b)
WACC = 6.30% (E(3.69b)/V(5.80b) * Re(9.42%) + D(2.11b)/V(5.80b) * Rd(1.27%) * (1-Tc(0.35)))
Discount Rate = 9.42% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.88%
[DCF Debug] Terminal Value 78.65% ; FCFF base≈397.7m ; Y1≈261.1m ; Y5≈119.1m
Fair Price DCF = 22.55 (EV 3.38b - Net Debt 2.07b = Equity 1.31b / Shares 58.0m; r=6.30% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -3.54 | EPS CAGR: -17.43% | SUE: 0.08 | # QB: 0
Revenue Correlation: -14.25 | Revenue CAGR: -9.62% | SUE: 0.09 | # QB: 0
EPS next Quarter (2026-03-31): EPS=4.03 | Chg30d=+0.035 | Revisions Net=-2 | Analysts=7
EPS current Year (2026-09-30): EPS=4.34 | Chg30d=+0.028 | Revisions Net=+8 | Growth EPS=+16.1% | Growth Revenue=+0.7%
EPS next Year (2027-09-30): EPS=4.98 | Chg30d=-0.014 | Revisions Net=-1 | Growth EPS=+14.7% | Growth Revenue=+2.3%
Additional Sources for SMG Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle